DETAIL

DETAIL INFORMATION

Maanshan Fengyuan Pharmaceutical Co., Ltd.

Published:

2018-08-07

Source:

Author:

Maanshan Fengyuan Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Anhui Fengyuan Pharmaceutical Co., Ltd. It was established in June 2008 on the basis of the original "Anhui Fengyuan Pharmaceutical Co., Ltd. Ma'anshan Pharmaceutical Factory" with a registered capital of 145.5 million yuan. Its predecessor was Maanshan Biochemical Pharmaceutical Factory, which was founded in 1970 and mainly produces biochemical drugs. Maanshan Biochemical Pharmaceutical Factory participated in Fengyuan Pharmaceutical Co., Ltd. in 2000 and was listed on the Shenzhen Stock Exchange. In February 2006, due to the needs of urban planning and company development, it was relocated to the Economic and Technological Development Zone, covering an area of 145 mu.

Maanshan Fengyuan Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Anhui Fengyuan Pharmaceutical Co., Ltd. It was established in June 2008 on the basis of the original "Anhui Fengyuan Pharmaceutical Co., Ltd. Ma'anshan Pharmaceutical Factory". With a capital of 145.5 million yuan, its predecessor was Maanshan Biochemical Pharmaceutical Factory, which was founded in 1970 and mainly produces biochemical drugs. In 2000, Maanshan Biochemical Pharmaceutical Factory participated in Fengyuan Pharmaceutical Co., Ltd. and was listed on the Shenzhen Stock Exchange. In February 2006, due to the needs of urban planning and company development, it was relocated to the Economic and Technological Development Zone, covering an area of ​​145 mu.

The company currently has 7 GMP production lines, and has three dosage forms of freeze-dried powder injection, small volume injection and API. The products cover the fields of digestive system, gynecological drugs, hormone drugs, antibacterial drugs, etc., including acetic acid for a class of new drugs for injection Alanorelin, Class II New Drug Ibutilide Fumarate Injection, Class IV New Drug Gonarelin for Injection, Class Five New Drug Dexamethasone Sodium Phosphate for Injection and Vitamin B6 for Injection, and Coenzyme A for Injection of Biochemical Products , oxytocin injection and other 112 approvals.

Maanshan Fengyuan Pharmaceutical Co., Ltd. invested 101 million yuan in 2013 to build three non-terminally sterilized injection production lines. The production lines meet the new GMP certification requirements of the State Food and Drug Administration. The annual production capacity is 100 million bottles of non-hormone freeze-dried powder injections, 50 million bottles of hormone-based freeze-dried powder injections, and 150 million small-volume injections.

In March 2016, Maanshan Fengyuan Pharmaceutical Co., Ltd. invested 100 million yuan again to build a production workshop with an annual output of 50 million cartridges for water injection, which is used to produce oral local anesthetic compound articaine hydrochloride injection. At present, similar products listed in the United States, Europe, Canada and other countries are packaged in cartridges. The new production line of our company will fill the blank of the cartridge-free product in the field of domestic anesthetic injections, and will also be able to meet the extensive demand for cartridge anesthetics due to the rapid development of domestic comfortable oral treatment.

Maanshan Fengyuan Pharmaceutical Co., Ltd. currently has 240 employees, of which more than 38% are professional and technical personnel. At present, the company's total assets are 600 million yuan. In 2018, it achieved sales revenue of 404.6 million yuan and tax payment of 53.61 million yuan; in 2019, it achieved sales revenue of 442.5 million yuan and tax payment of 41.46 million yuan; in 2020, the annual sales revenue was 373 million yuan and tax payment was 45.1 million yuan. ;2021 annual sales revenue of 432 million yuan and tax payment of 24 million yuan

Maanshan Fengyuan Pharmaceutical Co., Ltd. has always attached importance to technological innovation, actively introduced high-tech equipment and technology at home and abroad, and established a complete quality management and monitoring system. The company has 20 product invention patents and 14 high-tech products. In 2008, 2011, 2014, 2017 and 2020, the company was rated as a "high-tech enterprise" for five consecutive times. In 2014, he won a scientific and technological research achievement in Anhui Province, and in 2018, he won the third prize of Anhui Province Science and Technology Award.

Relying on superior production conditions, strong research and development strength, high-quality after-sales service, and perfect quality assurance, the company has laid a foundation for the development of the enterprise.

Back

Anhui Fengyuan Likang Pharmaceutical Co., Ltd.

Relative news

Warm congratulations to Fengyuan Pharmaceutical on the successful convening of the 2013 annual work summary and commendation conference

On January 25, 2014, Fengyuan Pharmaceutical held the 2013 annual work summary and commendation meeting in the multi-functional hall on the sixth floor of the headquarters. The headquarters executives, managers and employees of various functional departments, the leadership team of subsidiaries and advanced individuals participated in the meeting. Meeting. The meeting first summarized the work in 2013 and looked forward to 2014. At the same time, advanced individuals and groups with outstanding performance were commended. After the meeting, the company arranged a wonderful "2014 Welcome Party" and a rich dinner.

2022-06-30

Revisiting the history, cherishing the present, and looking forward to the future---remember the July 1 Party Member Activity Conference of Fengyuan Pharmaceutical Party Branch

At 15:00 on July 1, 2015, the party committee of Fengyuan Pharmaceutical held a party member activity meeting for the 94th anniversary of the founding of the party in the company's No. 1 conference room. The conference was presided over by Ru Tianle, Secretary of the Party Committee of the company. The event was divided into two main agendas: the swearing-in ceremony of new party members and the training of party history class. All party members stood up and sang "The Internationale" to kick off the event. The first item of the agenda, first of all, Ru Tianle, secretary of the party committee, read out the list of prospective party members and led three new party members to take the oath of joining the party facing the national flag. The old party member representative Xiao Guosong made a speech, mainly reporting to the participating party members his experience in work and life as an old party member, advocating

2022-06-30

Practical training in corporate strategic thinking and strategy formulation

From April 12th to 13th, 2015, the company organized the training of "Enterprise Strategic Thinking and Strategy Formulation Practice", and the middle and senior managers of the company and the senior managers of subsidiaries participated in the training. The following are training pictures:

2022-06-30

Warmly welcome the leaders of Wuhu City to visit Wuwei Pharmaceutical Factory for inspection and guidance

On March 3, 2015, Wuhu Municipal Party Committee Secretary Gao Dengbang, Mayor Pan Zhaohui, Deputy Mayor Lin Xuwen and some other members of the four major groups, the principals of various counties and districts and other government leaders visited Fengyuan Pharmaceutical Wuwei Pharmaceutical Factory Fudu New Plant for inspection Guidance, the company's general manager Gao Ji, Wuwei pharmaceutical factory director Hu Baowen accompanied the whole process. First of all, the company's general manager, on behalf of all the company's employees, extended a warm welcome to all the leaders, and made a detailed report on Anhui Fengyuan Pharmaceutical Co., Ltd., the fundraising project of Wuwei Pharmaceutical Factory, and the product planning of Wuwei Pharmaceutical Factory in the next five years. While providing the physical samples, he introduced the Wuwei Pharmaceutical Factory to the inspection leaders.

2022-06-30

图片名称

86-0551-64846100

图片名称

127841476@qq.com

大兴

CopyRight © 2022 Anhui BBCA Pharmaceuticals Co., Ltd  Powered by：www.300.cn  SEO

京ICP备10002622号-38